• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士警察队列中 COVID-19 疫苗接种后的血清监测。

Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohort.

机构信息

Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Division Operations, Cantonal Police Bern, Bern, Switzerland.

出版信息

Immun Inflamm Dis. 2022 Jul;10(7):e640. doi: 10.1002/iid3.640.

DOI:10.1002/iid3.640
PMID:35759237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9168549/
Abstract

INTRODUCTION

To assess the risk for COVID-19 of police officers, we are studying the seroprevalence in a cohort. The baseline cross-sectional investigation was performed before a vaccination campaign in January/February 2021, and demonstrated a seroprevalence of 12.9%. Here, we demonstrate serosurveillance results after a vaccination campaign.

METHODS

The cohort consists of 1022 study participants. The 3- and 6-month follow-up visits were performed in April/May and September 2021. Data on infection and vaccination rates were obtained via measuring antibodies to the nucleocapsid protein and spike protein and online questionnaires.

RESULTS

The mean age of the population was 41 (SD 8.8) years, 72% were male and 76% had no comorbidity. Seroconversion was identified in 1.05% of the study population at the 3-month visit and in 0.73% at the 6-month visit, resulting in an infection rate of 1.8% over a time period of 6 months. In comparison, the infection rate in the general population over the same time period was higher (3.18%, p = .018). At the 6-month visit, 77.8% of participants reported being vaccinated once and 70.5% twice; 81% had an anti-S antibody titer of >250 U/ml and 87.1% of ≥2 U/ml. No significant association between infection and job role within the department, working region, or years of experience in the job was found. Anti-spike antibody titers of vaccinated study participants showed a calculated decreasing trend 150-200 days after the second vaccine dose.

CONCLUSION

These data confirm the value of the vaccination campaign in an exposed group other than healthcare professionals.

摘要

简介

为了评估警察感染 COVID-19 的风险,我们正在对一个队列进行血清流行率研究。基线横断面调查是在 2021 年 1 月/2 月疫苗接种活动之前进行的,结果显示血清阳性率为 12.9%。在这里,我们展示了疫苗接种活动后的血清监测结果。

方法

该队列包括 1022 名研究参与者。在 2021 年 4 月/5 月和 9 月进行了 3 个月和 6 个月的随访。通过测量核衣壳蛋白和刺突蛋白抗体以及在线问卷调查来获取感染和疫苗接种率数据。

结果

人群的平均年龄为 41(SD 8.8)岁,72%为男性,76%无合并症。在 3 个月访视时,研究人群中有 1.05%发生血清转化,在 6 个月访视时,有 0.73%发生血清转化,导致 6 个月内感染率为 1.8%。相比之下,同一时期普通人群的感染率更高(3.18%,p=0.018)。在 6 个月访视时,77.8%的参与者报告接种了一次,70.5%接种了两次;81%的人抗-S 抗体滴度>250 U/ml,87.1%的人抗-S 抗体滴度≥2 U/ml。在部门内部的工作角色、工作区域或工作经验年限方面,未发现感染与工作之间存在显著关联。接种疫苗的研究参与者的抗刺突抗体滴度在第二次疫苗接种后 150-200 天呈计算出的下降趋势。

结论

这些数据证实了疫苗接种活动在医疗保健专业人员以外的暴露人群中的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab8/9168549/e60576ebb8ae/IID3-10-e640-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab8/9168549/a02f91887dfa/IID3-10-e640-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab8/9168549/d186d39b1f8b/IID3-10-e640-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab8/9168549/e60576ebb8ae/IID3-10-e640-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab8/9168549/a02f91887dfa/IID3-10-e640-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab8/9168549/d186d39b1f8b/IID3-10-e640-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ab8/9168549/e60576ebb8ae/IID3-10-e640-g002.jpg

相似文献

1
Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohort.瑞士警察队列中 COVID-19 疫苗接种后的血清监测。
Immun Inflamm Dis. 2022 Jul;10(7):e640. doi: 10.1002/iid3.640.
2
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
3
Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.意大利警察大样本队列中 SARS-CoV-2 的血清阳性率。
Int J Environ Res Public Health. 2021 Nov 20;18(22):12201. doi: 10.3390/ijerph182212201.
4
Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco).摩洛哥马拉喀什接种疫苗的医护人员中 SARS-CoV-2 抗体的血清阳性率。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221133697. doi: 10.1177/03946320221133697.
5
[COVID-19 infections and effectiveness of the vaccination among healthcare workers].[医护人员中的新冠病毒感染情况及疫苗接种效果]
Orv Hetil. 2023 Feb 5;164(5):163-171. doi: 10.1556/650.2023.32709.
6
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.
7
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.根据 2020 年 7 月至 2021 年 5 月的献血样本,估计美国感染和疫苗引起的 SARS-CoV-2 血清流行率。
JAMA. 2021 Oct 12;326(14):1400-1409. doi: 10.1001/jama.2021.15161.
8
SARS COV-2 anti-nucleocapsid and anti-spike antibodies in an emergency department healthcare worker cohort: September 2020 - April 2021.2020 年 9 月至 2021 年 4 月急诊科医护人员队列中 SARS-CoV-2 的核衣壳和刺突抗体。
Am J Emerg Med. 2022 Apr;54:81-86. doi: 10.1016/j.ajem.2022.01.055. Epub 2022 Feb 2.
9
Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.德国医护人员在 COVID-19 大流行第三波末期 SARS-CoV-2 感染率低且疫苗诱导的免疫力高。
Int J Hyg Environ Health. 2021 Sep;238:113851. doi: 10.1016/j.ijheh.2021.113851. Epub 2021 Sep 25.
10
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.比利时首次 BNT162b2 疫苗接种活动 6 个月后,接种疫苗的养老院居民和工作人员中 SARS-CoV-2 抗体流行率下降:一项前瞻性队列研究。
Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361.

引用本文的文献

1
Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait.新型冠状病毒2型血清流行率的变化模式:科威特普通人群的情况快照
Vaccines (Basel). 2023 Feb 2;11(2):336. doi: 10.3390/vaccines11020336.
2
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020-2022.2020-2022 年智利两个城市人群队列中针对 SARS-CoV-2 病毒的天然和获得性免疫的血清流行率。
Viruses. 2023 Jan 10;15(1):201. doi: 10.3390/v15010201.

本文引用的文献

1
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis.美国县级新冠疫苗接种覆盖率以及新冠病例和死亡发生率:一项生态分析。
Lancet Reg Health Am. 2022 May;9:100191. doi: 10.1016/j.lana.2022.100191. Epub 2022 Jan 31.
2
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England.英格兰 COVID-19 加强疫苗对与 COVID-19 相关症状、住院和死亡的有效性。
Nat Med. 2022 Apr;28(4):831-837. doi: 10.1038/s41591-022-01699-1. Epub 2022 Jan 14.
3
A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study.
一项针对警察队列中2019冠状病毒病血清流行率的多维横断面分析:PoliCOV-19研究。
Open Forum Infect Dis. 2021 Oct 16;8(12):ofab524. doi: 10.1093/ofid/ofab524. eCollection 2021 Dec.
4
Protection against Covid-19 by BNT162b2 Booster across Age Groups.辉瑞-BioNTech 疫苗加强针在各年龄段对预防新冠病毒的保护作用
N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 8.
5
Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.意大利警察大样本队列中 SARS-CoV-2 的血清阳性率。
Int J Environ Res Public Health. 2021 Nov 20;18(22):12201. doi: 10.3390/ijerph182212201.
6
Prospective study on COVID-19 seroprevalence and behavioural patterns in military personnel from the Southern Brazil.巴西南部军事人员中新冠病毒血清流行率及行为模式的前瞻性研究。
Infect Dis (Lond). 2022 Mar;54(3):228-231. doi: 10.1080/23744235.2021.1995039. Epub 2021 Nov 16.
7
Waning Immunity after the BNT162b2 Vaccine in Israel.以色列接种 BNT162b2 疫苗后的免疫力下降。
N Engl J Med. 2021 Dec 9;385(24):e85. doi: 10.1056/NEJMoa2114228. Epub 2021 Oct 27.
8
Covid-19: Italy sees protests against mandatory health passports for workplaces.新冠疫情:意大利出现针对工作场所强制健康通行证的抗议活动。
BMJ. 2021 Oct 20;375:n2575. doi: 10.1136/bmj.n2575.
9
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.卡塔尔:BNT162b2 疫苗对 SARS-CoV-2 感染的保护作用逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e83. doi: 10.1056/NEJMoa2114114. Epub 2021 Oct 6.
10
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.辉瑞-BioNTech 新冠疫苗接种 6 个月后免疫体液反应逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.